Angiotensin peptides and nitric oxide in cardiovascular disease

Kaushik P Patel1, Harold D Schultz

  • 11 Department of Cellular and Integrative Physiology, University of Nebraska Medical Center , Omaha, Nebraska.

Abstract

Insights

The renin-angiotensin system (RAS) is crucial for cardiovascular health. Imbalances in RAS pathways, particularly involving oxidative stress, contribute to cardiovascular diseases like hypertension and heart failure.

Area of Science:

  • Cardiovascular Physiology
  • Renal Function
  • Neuroendocrinology

Background:

  • The renin-angiotensin system (RAS) is vital for cardiovascular and renal homeostasis.
  • A balance between the ACE/Ang II/AT1 receptor and ACE2/Ang-(1-7)/Mas receptor axes is critical for normal function.
  • Imbalances favoring the ACE/Ang II/AT1 axis are linked to cardiovascular diseases (CVD).

Purpose of the Study:

  • To elucidate the mechanisms disrupting RAS regulation in CVD.
  • To understand the role of oxidative and nitrosative pathways in neural control of circulation.
  • To investigate the interplay between redox mechanisms and RAS enzyme/receptor activity.

Main Methods:

  • Analysis of renin-angiotensin system (RAS) pathways.
  • Investigation of ACE and ACE2 expression and function.
  • Exploration of neural control mechanisms involving oxidative and NO• pathways.

Main Results:

  • Key mechanisms disrupting Ang II and Ang-(1-7) signaling in CVD remain unclear.
  • ACE and ACE2 expression and function appear interdependent.
  • Oxidative and nitrosative pathway interactions may be central to disease pathogenesis.

Conclusions:

  • Understanding redox mechanisms controlling RAS components is key to understanding local tissue RAS in health and disease.
  • Imbalances in RAS signaling contribute significantly to cardiovascular disease progression.
  • Further research into the interplay of redox and RAS is warranted.

Related Concept Videos

Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: